DIT vs IVFH: stock comparison and AI forecast
Amcon Distributing Co (DIT) and Innovative Food Holdings Inc (IVFH) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
DIT Amcon Distributing Co
- Price
- $60.90 -31.8% · 6M
- Market Cap
- $59M
- P/E Ratio
- 32.3x
- Size
- small-cap
- AI Forecast
IVFH Innovative Food Holdings Inc
- Price
- $0.16 -49.0% · 6M
- Market Cap
- $9M
- P/E Ratio
- 3.2x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- DIT is 6.9 times larger than IVFH by market capitalization ($59M against $9M).
- IVFH trades at 3.1 times trailing earnings, DIT at 32.3 times.
- Over the last six months DIT returned -31.8% and IVFH -49.0%.
- IVFH turns 1.1% of its revenue into net income, against 0.1% for DIT.
- DIT carries 2.46 times debt per unit of equity, against 0.44 times for IVFH.
- DIT yields 1.10% in dividends; IVFH pays none.
- Both companies share the SEC industry classification Wholesale-Groceries, General Line.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | DIT | IVFH |
|---|---|---|
| Market Cap | $59M | $9M |
| P/E Ratio | 32.26x | 3.15x |
| P/B Ratio | 0.51x | 1.01x |
| Dividend Yield | 1.10% | – |
| EPS | $1.88 | $0.05 |
| Book Value/Share | $118.32 | $0.16 |
| Revenue/Share | $3101.70 | $0.83 |
| FCF/Share | $2.79 | $0.01 |
Profitability & Margins
| Metric | DIT | IVFH |
|---|---|---|
| ROE | 1.6% | 6.0% |
| ROA | 0.5% | 4.2% |
| ROIC | 4.3% | 38.4% |
| Gross Margin | 6.3% | 29.3% |
| Operating Margin | 0.4% | 7.4% |
| Net Margin | 0.1% | 1.1% |
| EBT Margin | 0.1% | 8.2% |
| Tax Rate | 37.5% | 2.9% |
Financial Health
| Metric | DIT | IVFH |
|---|---|---|
| Current Ratio | 2.75x | 2.88x |
| Quick Ratio | 1.05x | 2.06x |
| D/E Ratio | 2.46x | 0.44x |
| Financial Leverage | 3.46x | 1.44x |
| Interest Coverage | 2.5x | 2.0x |
| Working Capital | $159M | $7M |
Cash Flow
| Metric | DIT | IVFH |
|---|---|---|
| Operating Cash Flow | $15M | $750K |
| Free Cash Flow | $3M | $820K |
| Capital Spending | -$13M | $70K |
| OCF Growth YoY | -46.6% | – |
| FCF Growth YoY | -83.6% | – |
| FCF/Sales | 0.1% | 1.8% |
| CapEx/Sales | 0.4% | 0.1% |
Operational Efficiency
| Metric | DIT | IVFH |
|---|---|---|
| Asset Turnover | 7.58x | 3.69x |
| Receivables Turnover | 38.9x | 8.5x |
| Inventory Turnover | 18.5x | 11.1x |
| Fixed Assets Turnover | 27.8x | 37.3x |
| Days Sales Outstanding | 9 days | 43 days |
| Days Inventory | 20 days | 33 days |
| Payables Period | 7 days | 23 days |
| Cash Conversion Cycle | 22 days | 53 days |
Income Statement
| Metric | DIT | IVFH |
|---|---|---|
| Total Revenue | $3.03B | $45M |
| Operating Income | $13M | $3M |
| Net Income | $2M | $510K |
| SG&A Expense | $169M | $10M |
| Cost of Goods Sold | $2.84B | $32M |
Dividend & Shareholder Information
| Metric | DIT | IVFH |
|---|---|---|
| Dividends Per Share | $0.67 | – |
| Payout Ratio | 35.6% | – |
| Shares Outstanding | 1M | 55M |
| Net Income Growth | 36.8% | -44.2% |
| EPS Growth | 19.8% | 2.0% |
DIT vs IVFH: stock comparison and AI forecast
Which is bigger, DIT or IVFH?
DIT is 6.9 times larger than IVFH by market capitalization ($59M against $9M).
Which is cheaper on earnings, DIT or IVFH?
IVFH trades at 3.1 times trailing earnings, DIT at 32.3 times.
Which stock performed better over the last six months, DIT or IVFH?
Over the last six months DIT returned -31.8% and IVFH -49.0%.
Which one does Intratio's AI model rank higher, DIT or IVFH?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.